Sweden raises SEK 10 billion at 1.386 % with 50-year bond
Sweden raises SEK 10 billion at1.386%with 50-year bond
The Kingdom of Sweden raised SEK 10 billion at a yield of 1.386 per cent in the planned sale of a 50-year government bond. The new bond will be the longest outstanding loan in Sweden’s central government debt.
More than 80 investors participated in the syndicated sale with the total bid volume reaching above SEK 52 billion. Syndication means that a group of banks executes the transaction at terms approved by the issuer. The final pricing was fixed at 45 basis points above the yield on the Swedish government bond that was formerly the longest, maturing in just over 24 years.
– I am pleased that we were able to extend the Swedish government bond curve to 50 years through this transaction. With Sweden’s strong state finances as a foundation, we have again shown that we can attract a broad investor base, says Johan Bergström, Acting Head of Funding at the Swedish National Debt Office.
The Debt Office will gradually build up the outstanding stock of the new bond SGB 1064 by issuing smaller volumes in regular auctions.
Terms and conditions
|Issuer||Kingdom of Sweden|
|Size||SEK 10 billion|
|Maturity date||23 June 2071|
|Yield of SGB 1064 versus yield of SGB 1063 maturing on 24 November 2045||45 basis points|
|Lead managers||Barclays, Danske Markets, Handelsbanken Markets, Natwest Markets, Nordea Markets, SEB, Swedbank|
Distribution by investortype
|Fund managers||29 %|
|Insurance and pension companies||27 %|
|Hedge funds||18 %|
|Central banks/ public institutions||17 %|
Distribution by region
|Other Nordics||15 %|
|Asia & Middle east||14 %|
|Rest of Europe||12 %|
Johan Bergström, Acting Head of Funding, +46 8 613 45 68
Press office, firstname.lastname@example.org, +46 8 613 47 01
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Yara continues its transformation with divestment of Salitre phosphate mining project in Brazil1.8.2021 21:00:00 CEST | Press release
Oslo, 1 August 2021: Yara has signed a Share Purchase Agreement with EuroChem to sell its Salitre phosphate mining project for a cash consideration of USD 410 million. Yara’s ongoing transformation has a strategic focus on food solutions, premium products and enabling the hydrogen economy. Salitre remains an attractive project, but as previously communicated the project progress has been impacted by Covid 19, and significant construction time and capital expenditure remains to reach completion. The Salitre divestment therefore supports Yara’s transformation by reallocating capital and risk appetite in the coming years towards Yara’s strategic focus areas. “This transaction allows us to further sharpen our strategic focus, based on our strong competitive edges. Yara Brazil will continue to play an essential role in this growth agenda, and this transaction enables that growth to be driven with a sharper downstream focus,” said Svein Tore Holsether, President and Chief Executive Officer o
Scientists Narrow Search For Mysterious Mad Trapper To Sweden30.7.2021 23:21:41 CEST | Press release
EDMONTON, Alberta and HOUSTON, July 30, 2021 (GLOBE NEWSWIRE) -- This month marks the 90th anniversary of the arrival of the fugitive known as ‘The Mad Trapper of Rat River’ to the Canadian North and the revelation of an important new clue to identifying the mysterious fugitive. Following the unprovoked shooting of RCMP Constable A.W. King in December 1931, the unknown criminal who identified himself by the pseudonym Albert Johnson led an RCMP posse on seven-week manhunt across the desolate Arctic landscape. During the pursuit, the Mad Trapper shot and killed Constable E. Millen. With the help of indigenous guides the Mad Trapper was located and killed during a gun battle on the Eagle River on February 17, 1932. Despite the RCMP releasing photos of the Mad Trapper and receiving hundreds of tips from around the world his identity was never established In 2007, Myth Merchant Films of Alberta Canada secured permission for a team of forensic experts to exhume the body of the Mad Trapper in
KBC Group: KBC remains strongly capitalised under 2021 EU-wide EBA stress test30.7.2021 18:15:00 CEST | Press release
Press Release Outside trading hours - Regulated information* Brussels, 30 July 2021 (6.15 p.m. CEST) KBC remains strongly capitalised under 2021 EU-wide EBA stress test KBC notes the announcements made today by the European Banking Authority (EBA) regarding the results of the 2021 EU-wide stress test. A brief set of slideson the KBC data is available at www.kbc.com. The impact of the stress test on KBC’s fully loaded Common Equity Tier-1 (CET1) ratio of 17.58% at year-end 2020 caused this ratio to increase by 1.92 percentage points to 19.50% at year-end 2023 under the base scenario. Under the adverse scenario, KBC’s fully loaded CET1 ratio would fall by 3.51 percentage points to 14.07%1. KBC’s leverage ratio, which stood at 6.42% at year-end 2020, would increase to 7.09% under the base scenario and decrease to just 5.53% under the adverse scenario. Commenting on today’s announcements, Johan Thijs, KBC Group CEO had this to say: ‘The results of this regular, theoretical exercise conduct
EBA reports on outcome of 2021 EU-wide stress test30.7.2021 18:10:23 CEST | Press release
EBA reports on outcome of 2021 EU-wide stress test ING Group was subject to the 2021 EU-wide stress test conducted by the European Banking Authority (EBA), in cooperation with the European Central Bank (ECB), the European Systemic Risk Board (ESRB) and De Nederlandsche Bank. ING Group notes the announcements made today by the EBA on the stress test and fully acknowledges the outcomes of this exercise. The 2021 EU-wide stress test does not contain a pass/fail threshold and instead is designed to be used as an important source of information for the purposes of the Supervisory Review and Evaluation Process. The results will assist competent authorities in assessing ING Group’s ability to meet applicable prudential requirements under stressed scenarios. The adverse stress test scenario was set by the ECB/ESRB and covers a three-year time horizon (2020-2023). The stress test has been carried out applying a static balance sheet assumption as at December 2020, and therefore does not take int
Marc Peeters, new member in supervisory board of Intervest Offices & Warehouses30.7.2021 18:00:00 CEST | Press release
The supervisory board of Intervest has co-opted ir. Marc Peeters to take up a mandate with effect from 1 August 2021 as an independent member of the supervisory board. His final appointment will be proposed at the next general meeting of Intervest. Attachment New member supervisory board
XBiotech Announces Payment of Dividend to Holders of Common Stock30.7.2021 17:03:00 CEST | Press release
Company distributed USD $75 Million to Shareholders AUSTIN, Texas, July 30, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) has completed payment to holders of its Common Stock of a previously announced dividend in the amount of USD$75,000,000.00. Based on the number of shares of Common Stock issued and outstanding on the record date for the dividend, each such holder received USD$2.47 per share on July 23, 2021. In the past 18 months, XBiotech’s balance sheet strength has enabled the company to offer approximately USD$495 million in cash to shareholders by way of stock repurchase and dividend distribution. The financial strength of the Company owes to the successful development of a pipeline of True Human™ antibody drug candidates. John Simard stated that “XBiotech was pleased to be able to reward its shareholders with a $2.47 per share dividend. Our ability to continue to provide opportunities for shareholders to monetize stock in XBiotech, reflects the strength of
Jānis Buks elected as the Chairperson of the Management Board of JSC Olainfarm30.7.2021 12:41:00 CEST | Press release
Today, on July 30, the Supervisory Council of JSC Olainfarm has elected Jānis Buks as the Chairperson of the Management Board. He has significant professional experience, which, together with the team of JSC Olainfarm, will contribute to the company's growth, stability, and predictability. Jānis Buks was the Deputy Chairperson of the Supervisory Council of JSC Olainfarm from April 4, 2019 to June 17, 2021. “JSC Olainfarm is a Latvian pharmaceutical success story, however, the conflicts of recent years have overshadowed the success. We need to ensure stability and predictability, both for future plans and for the group as a whole. It is time to restart Olainfarm and build back the company's reputation, continue to grow and to be a stable and predictable partner and employer,” emphasizes Jānis Buks, Chairperson of the Management Board of JSC Olainfarm. J. Buks graduated from the Faculty of Law of the University of Latvia, obtaining a bachelor's degree in law. He improved his knowledge in